Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan
- PMID: 18552242
Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan
Abstract
Background: In patients on continuous ambulatory peritoneal dialysis (CAPD), dialysate calcium concentration has a strong influence on correction of serum calcium, phosphorus, and parathyroid hormone (PTH); however, the optimal concentration of Ca in PD solution is still uncertain. The aim of the survey reported here was to evaluate the prevalence of patients treated with standard- [SCD (approximately 3.25 - 4.0 mEq/L)] or low-calcium [LCD (approximately 1.8 - 2.5 mEq/L)] dialysate and differences in the clinical effects for correction of abnormalities in divalent ions and PTH.
Materials and methods: We used a questionnaire to survey 333 peritoneal dialysis facilities nationwide in Japan. Then, we analyzed serum Ca, P, and PTH levels and the prescription rates for CaCO(3) as a P binder and for vitamin D (VitD) analogs.
Results: The 2384 CAPD patients enrolled in this analysis had a mean age of 60.5 +/- 14.2 years and a mean duration of CAPD of 44.1 +/- 39.2 months. The prevalences of SCD, LCD, and combination of SCD and LCD were, respectively, 49%, 50%, and 1% at initiation, and 40%, 38%, and 22% at the time of the survey. In 735 and 876 patients respectively, LCD and SCD had been prescribed from initiation to the time of the survey. In these two groups, we observed no difference in initiation and current serum levels of Ca and P. But prescription rates for CaCO(3) and VitD analogs were higher in the LCD group than in the SCD group, and PTH levels were higher in the LCD group than in the SCD group.
Conclusions: A beneficial effect of LCD was revealed in the increased doses of CaCO(3) and VitD analogs seen in that group without the occurrence of hypercalcemia; however, PTH levels in that group were not maintained within an acceptable range. The survey suggests that more serious attention should be paid to the Ca concentration in peritoneal dialysate so as to lessen mineral and PTH disorders in CAPD.
Similar articles
-
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.Perit Dial Int. 1996 May-Jun;16(3):260-8. Perit Dial Int. 1996. PMID: 8761540 Clinical Trial.
-
Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.J Intern Med. 1998 Aug;244(2):121-31. doi: 10.1046/j.1365-2796.1998.00323.x. J Intern Med. 1998. PMID: 10095798
-
Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize?Perit Dial Int. 1997 Nov-Dec;17(6):554-9. Perit Dial Int. 1997. PMID: 9655154 Review.
-
Comparison and analysis of low-calcium and standard-calcium dialysates in patients undergoing continuous ambulatory peritoneal dialysis and their effects on calcium-phosphorus metabolism indicators.Ther Apher Dial. 2025 Aug;29(4):646-652. doi: 10.1111/1744-9987.70038. Epub 2025 May 22. Ther Apher Dial. 2025. PMID: 40401560
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium.Front Physiol. 2018 Nov 20;9:1643. doi: 10.3389/fphys.2018.01643. eCollection 2018. Front Physiol. 2018. PMID: 30524306 Free PMC article.
-
Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid.Life (Basel). 2025 Feb 11;15(2):279. doi: 10.3390/life15020279. Life (Basel). 2025. PMID: 40003688 Free PMC article. Review.